Genmark Diagnostics Stock Company Profile

Description

GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, commercializes, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology. Its products include XT-8 system that enables reference laboratories and hospitals to perform a range of molecular diagnostic and research tests with a workstation and disposable test cartridge. The company offers eight diagnostic tests for use with its XT-8 system that includes Respiratory Viral Panel, Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test, Thrombophilia Risk Test, hepatitis C virus, genotyping tests, and custom manufactured reagents, as well as provides versions for other research-based and pharmacogenomics products. It also provides ePlex system, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using the ePlex system to place the patient sample into the test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.